APA (7th ed.) Citation

Horikawa, H., Kurihara, Y., Funakoshi, T., Umegaki‐Arao, N., Takahashi, H., Kubo, A., . . . Yamagami, J. (2018). Unique clinical and serological features of bullous pemphigoid associated with dipeptidyl peptidase‐4 inhibitors. British journal of dermatology (1951), 178(6), 1462-1463. https://doi.org/10.1111/bjd.16479

Chicago Style (17th ed.) Citation

Horikawa, H., et al. "Unique Clinical and Serological Features of Bullous Pemphigoid Associated with Dipeptidyl Peptidase‐4 Inhibitors." British Journal of Dermatology (1951) 178, no. 6 (2018): 1462-1463. https://doi.org/10.1111/bjd.16479.

MLA (9th ed.) Citation

Horikawa, H., et al. "Unique Clinical and Serological Features of Bullous Pemphigoid Associated with Dipeptidyl Peptidase‐4 Inhibitors." British Journal of Dermatology (1951), vol. 178, no. 6, 2018, pp. 1462-1463, https://doi.org/10.1111/bjd.16479.